Compounded tirzepatide

Sold by Amble · Injection, pen · every compounded tirzepatide record

Price

History

• August 31, 2026 — Entry added to the register

Sourcing and terms

Notes

1. 1. August 31, 2026 — Correction, August 31, 2026. An earlier version of this record carried a four-rung plan table — twelve months at $135, six at $145, three at $160, one at $179 — and a headline requiring the twelve-month plan at $1,620 charged today. That table is an inactive design variant: it sits in the page's code but is hidden, and nothing on the page reveals it. The table a reader actually sees has three rungs, and it prices six months at $135, not $145. The twelve-month rung and the $145 rate have been removed and the headline replaced.
2. 2. August 31, 2026 — The sentence "Total price represents a one time purchase paid upfront" is in the same hidden container and is rendered nowhere on the site. It has been removed from this record, which is why no rung above claims to be charged in full today: Amble publishes per-month rates for three terms and does not visibly say when it bills them.
3. 3. August 31, 2026 — Amble's compounded GLP-1 injections page reads: "Compounded GLP-1 injections A once-per-week GLP-1 weight loss injection. Unlimited 24/7 support No hidden fees No insurance required Same price, every dose Plan Per Month 6 Month $135 3 Month $160 1 Month $179".
4. 4. August 31, 2026 — Amble's bundled GLP-1 plus GIP and NAD+ injection is priced with no hidden terms or conflicting numbers: "Compounded GLP-1 + GIP & NAD+ Injection Same price, every dose No hidden fees Fast, free shipping No insurance required $250 1-month supply"
5. 5. August 31, 2026 — Amble's 'same price at every dose' promise comes with an expiration clause buried at the foot of the page. "Promotional Offers on joinamble.com Occasionally, joinamble.com may present promotional pricing or special introductory offers. These promotions are valid for 24 hours after they are removed from the website. The claim 'same price at every dose' is subject to the following: Pricing may change at any time due to supply or market conditions at the discretion of joinamble.com. Any 'same price at every dose' promotion expires within 24 hours of any price updates. Introductory or promotional pricing, including 'first month' offers, are not governed by the 'same price per dose' policy and only apply to full-price products as listed on the website."
6. 6. August 31, 2026 — Amble's providers are licensed physicians operating nationwide, and its medication is sourced from licensed pharmacies. Its FAQ states: "Who are the providers at Amble? Providers through Amble are physicians. They're licensed in all 50 states, and offer safe, high-quality, evidence-based treatment and care", and "Amble is available in all 50 states". On sourcing, the same FAQ states: "When prescribed, GLP-1 medications are dispensed by state-licensed, U.S. pharmacies. 503A pharmacies are licensed and regulated by state boards of pharmacy, while 503B outsourcing facilities are registered with FDA."
7. 7. August 31, 2026 — Amble's terms rule out refunds entirely: "All Products are non-refundable." The same terms name the company that actually fulfills prescriptions - "We may provide access to prescription fulfillment services offered by third-party pharmacy network providers. Bask Health, Inc. 555 Madison Avenue, Suite 1202 New York NY 10022" - and limit service to US residents: "Services are not available to users located outside the United States." The product page spells out Amble's own role: "Amble acts as a managed services provider and does not offer medical advice, fill prescriptions, or function as a licensed healthcare facility or pharmacy."

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.